Critical Care
(Sep 2020)
Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series
- Dian Fu,
- Ruiyuan Cao,
- Lei Zhao,
- Wei Li,
- Wu Zhong,
- Jiqiu Wen
Affiliations
- Dian Fu
- National Clinical and Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine
- Ruiyuan Cao
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology
- Lei Zhao
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology
- Wei Li
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology
- Wu Zhong
- National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology
- Jiqiu Wen
- National Clinical and Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine
- DOI
-
https://doi.org/10.1186/s13054-020-03288-5
- Journal volume & issue
-
Vol. 24,
no. 1
pp.
1
– 3
WeChat QR code
